All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-LY1635 | Anti-GSTK1 (16A11.E4.E3.E7) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 16A11.E4.E3.E7 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1636 | Anti-GSTK1 (9H351) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 9H351 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1637 | Anti-GSTK1 (CBLG1-3216) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-3216 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1638 | Anti-GSTK1 (CBLG1-3012) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-3012 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1639 | Anti-GSTK1 (CBLG1-2013) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-2013 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY3275 | Anti-GSTK1(16A11.E4.E3.E7) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 16A11.E4.E3.E7 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY3276 | Anti-GSTK1(9H351) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 9H351 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY3277 | Anti-GSTK1(CBLG1-3216) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-3216 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY3278 | Anti-GSTK1(CBLG1-3012) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-3012 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY3279 | Anti-GSTK1(CBLG1-2013) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-2013 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION